Adverse effects of 2,4-dichlorophenoxyacetic acid on rat cerebellar granule cell cultures were attenuated by amphetamine.
2,4-Dichlorophenoxyacetic acid (2,4-D), a worldwide-used herbicide, has been shown to produce a wide range of adverse effects in the health--from embryotoxicity and teratogenicity to neurotoxicity--of animals and humans. In this study, neuronal morphology and biochemical events in rat cerebellar granule cell (CGC) cultures have been analyzed to define some of the possible mechanisms involved in 2,4-D-induced cell death. For that purpose, amphetamine (AMPH) that has been shown to accelerate the recovery of several functions in animals with brain injury has been used as a pharmacologycal tool and was also investigated as a possible protecting agent. Addition of 2,4-D to CGC cultures produced a drastic decrease in cell viability, in association with an increased incidence of necrosis and apoptosis, and an increased level of reactive oxygen species, a decrease in glutathione content, and an abnormal activity of some enzymes with respect to the control group. The adverse effects of 2,4-D were partly attenuated in presence of AMPH. Some deleterious effects on several ultrastructural features of the cells, as well as the enhanced incidence of apoptosis, were partially preserved in AMPH-protected cultures as compared with those which were exposed to 2,4-D alone. The collected evidences (1) confirms the previously observed, deleterious effects of 2.4D on the same or a similar model; (2) suggests that the 2,4-D-induced apoptosis could have been mediated by or associated to an oxidative imbalance in the affected cells, and (3) shows some evidence of a protective effect of AMPH on 2,4-D-induced cell death, which could have been exerted through a reduction in the oxidative stress.
Bongiovanni
B
B
Laboratorio de Toxicología Experimental, Facultad de Ciencias Bioquímicas y Farmacéuticas, Universidad Nacional de Rosario, Suipacha 531, 2000 Rosario, Argentina. bettina.bongiovanni@gmail.com
Ferri
A
A
Brusco
A
A
Rassetto
M
M
Lopez
L M
LM
Evangelista de Duffard
A M
AM
Duffard
R
R
D015084:2,4-Dichlorophenoxyacetic Acid / Q000037:antagonists & inhibitors / Q000633:toxicity*; D000661:Amphetamine / Q000494:pharmacology*; D000818:Animals; D002470:Cell Survival / Q000187:drug effects / Q000502:physiology; D002478:Cells, Cultured; D002531:Cerebellum / Q000187:drug effects / Q000378:metabolism* / Q000648:ultrastructure; D003594:Cytoplasmic Granules / Q000187:drug effects / Q000378:metabolism* / Q000648:ultrastructure; D005260:Female; D008928:Mitochondria / Q000187:drug effects / Q000378:metabolism / Q000648:ultrastructure; D018696:Neuroprotective Agents / Q000494:pharmacology; D011247:Pregnancy; D011485:Protein Binding / Q000502:physiology; D051381:Rats; D017208:Rats, Wistar
D018696:Neuroprotective Agents; D015084:2,4-Dichlorophenoxyacetic Acid; D000661:Amphetamine
Brain Res Bull. 2003 Aug 30;61(4):365-74
12909279
Pharmacol Ther. 2003 Jul;99(1):45-53
12804698
J Lab Clin Med. 1967 Jul;70(1):158-69
6066618
Toxicol Appl Pharmacol. 2000 Sep 15;167(3):222-30
10986013
Cancer Res. 1997 May 15;57(10):1835-40
9157970
Int Rev Cytol. 2003;224:29-55
12722948
Braz J Med Biol Res. 2007 Aug;40(8):1011-24
17665037
J Cell Biol. 1963 Apr;17:208-12
13986422
Crit Rev Toxicol. 2002 Jul;32(4):233-57
12184504
J Biol Chem. 1969 Nov 25;244(22):6049-55
5389100
Brain Res. 2000 Jan 3;852(1):221-4
10661517
J Neurochem. 1992 Nov;59(5):1609-23
1402908
Prog Neurobiol. 2000 Dec;62(6):649-71
10880854
Toxicol Appl Pharmacol. 1999 Jan 15;154(2):117-25
9925795
J Biol Chem. 1952 Mar;195(1):133-40
14938361
Anal Biochem. 1977 Dec;83(2):346-56
603028
Comp Biochem Physiol C Toxicol Pharmacol. 2003 Aug;135(4):435-41
12965188
Neurotox Res. 2007 Feb;11(2):93-9
17449452
Biochem J. 1995 Apr 1;307 ( Pt 1):99-106
7718000
Crit Rev Neurobiol. 1996;10(3-4):291-316
8978984
Neurochem Res. 2002 Nov;27(11):1439-46
12512947
Exp Neurol. 2004 Sep;189(1):78-93
15296838
J Immunol Methods. 1983 Dec 16;65(1-2):55-63
6606682
Neuroscience. 2006 Feb;137(3):727-35
16338078
Cell Death Differ. 1997 Aug;4(6):516
16465273
Nitric Oxide. 2001 Feb;5(1):62-71
11178938
J Exp Med. 1997 Apr 21;185(8):1481-6
9126928
Hum Immunol. 2001 Jan;62(1):64-74
11165716
Brain Res. 2006 Jun 30;1097(1):224-9
16730669
Biomed Pharmacother. 2004 Jan;58(1):39-46
14739060
Chem Biol Interact. 2001 Sep 28;137(3):229-41
11566291
Neurotoxicol Teratol. 2003 Sep-Oct;25(5):607-13
12972074
Toxicology. 1999 Aug 13;136(1):41-52
10499849
Mol Chem Neuropathol. 1997 Apr;30(3):175-85
9165484
J Neurochem. 1987 Dec;49(6):1801-9
2890714
Food Chem Toxicol. 2003 Mar;41(3):385-93
12504171
Brain Res. 1999 Apr 24;826(1):53-62
10216196
Med Hypotheses. 2008;70(3):482-7
17728070
Redox Rep. 2001;6(2):77-90
11450987
J Biol Chem. 1999 Oct 8;274(41):29075-80
10506160
Neuropharmacology. 2000 Mar 3;39(5):852-9
10699450
Eur J Pharmacol. 2007 Sep 24;571(1):25-8
17618619
Chemosphere. 2001 May-Jun;43(4-7):801-5
11372868
J Immunol. 1995 Apr 1;154(7):3194-203
7897207
Drugs Aging. 2004;21(2):67-79
14960125
Neurotoxicology. 2001 Apr;22(2):221-32
11405254
Neurosci Lett. 2005 Jun 3;380(3):214-8
15862888
Free Radic Biol Med. 1994 Sep;17(3):235-48
7982629
Cell Biol Int. 2000;24(10):705-11
11023648
Toxicol Sci. 2000 Jul;56(1):133-40
10869461
Drug Chem Toxicol. 2007;30(1):17-30
17364861
J Toxicol Clin Toxicol. 2000;38(2):111-22
10778907